## Abstract Sympathetic neural control of cardiovascular function is essential for normal regulation of blood pressure and tissue perfusion. In the present review we discuss sympathetic neural mechanisms in human cardiovascular physiology and pathophysiology, with a focus on evidence from direct re
eigenPulse: Robust human identification from cardiovascular function
β Scribed by John M. Irvine; Steven A. Israel; W. Todd Scruggs; William J. Worek
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 949 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0031-3203
No coin nor oath required. For personal study only.
β¦ Synopsis
This paper presents eigenPulse, a new method for human identification from cardiovascular function. Traditional biometric techniques, e.g. face and fingerprint, have used eigen analysis to exploit databases with tens of thousands of entries. One drawback of traditional biometrics is that the credentials, for example, fingerprints, can be forged making the systems less secure. Previous research [S.A. Israel, J.M. Irvine, A. Cheng, M.D. Wiederhold, B.K. Wiederhold, ECG to identify individuals, Pattern Recognition 38(1) (2005) 138--142] demonstrated the viability of using cardiovascular function for human identification. By nature, cardiovascular function is a measure of liveness and less susceptible to forgery. However, the classification techniques presented in earlier work performed poorly over non-standard electrocardiogram (ECG) traces, raising questions about the percentage of the population that can be enrolled. This paper combines the traditional biometrics' use of eigen analysis and previous analysis of cardiovascular function to yield a more robust approach. The eigenPulse processing had a near 100% enrollment rate, with a corresponding higher overall performance.
π SIMILAR VOLUMES
To elucidate if genetic variants in the bradykinin B2 receptor (B2) gene occur that could affect receptor expression and function, we screened for mutations in the promoter and in the coding region of the human B2 gene. In our initial study we analyzed 92 consecutive, unrelated subjects (including 2
A partial clone of caldesmon, coding for the C-terminal 288 amino acids, was isolated from a human fetal liver cDNA library and sequenced. Expression of the clone in Escherichia coli produced a peptide called H1 (M r 32 549), which inhibited tropomyosin-enhanced actomyosin Mg2+-ATPase activity by 90